Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Optimal Foraging00:48

Optimal Foraging

13.7K
How animals obtain and eat their food is called foraging behavior. Foraging can include searching for plants and hunting for prey and depends on the species and environment.
13.7K
Restriction Enzymes01:11

Restriction Enzymes

35.7K
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
35.7K
Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
What are Estimates?01:06

What are Estimates?

8.2K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
8.2K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

215
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
215
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impacts of HIV-Related Service Interruptions During the COVID-19 Pandemic: Protocol of a Mixed Methodology Longitudinal Study.

AIDS and behavior·2023
Same author

Spatial Distribution of Parvalbumin-Positive Fibers in the Mouse Brain and Their Alterations in Mouse Models of Temporal Lobe Epilepsy and Parkinson's Disease.

Neuroscience bulletin·2023
Same author

The incidence and dynamic risk factors of chronic kidney disease among people with HIV.

AIDS (London, England)·2023
Same author

Association between clusters of antibodies against periodontal microorganisms and Alzheimer disease mortality: Evidence from a nationally representative survey in the USA.

Journal of periodontology·2023
Same author

CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway.

International journal of molecular sciences·2023
Same author

Hybridized Triboelectric-Electromagnetic Aeolian Vibration Generator as a Self-Powered System for Efficient Vibration Energy Harvesting and Vibration Online Monitoring of Transmission Lines.

ACS applied materials & interfaces·2023
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K

On restricted optimal treatment regime estimation for competing risks data.

Jie Zhou1, Jiajia Zhang1, Wenbin Lu2

  • 1Department of Epidemiology and Biostatistics, University of South Carolina, 915 Greene Street, Columbia, SC 29208, USA.

Biostatistics (Oxford, England)
|August 3, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a competing risks model to balance treatment benefits against severe side effects. The method optimizes individualized treatment regimes, minimizing risks for better patient outcomes in clinical settings.

Keywords:
Competing risks dataCumulative incidence functionOptimal treatment regimeSide effectsValue search method

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Operation of Laboratory Photobioreactors with Online Growth Measurements and Customizable Light Regimes
05:21

Operation of Laboratory Photobioreactors with Online Growth Measurements and Customizable Light Regimes

Published on: October 28, 2021

2.6K

Related Experiment Videos

Last Updated: Jan 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Operation of Laboratory Photobioreactors with Online Growth Measurements and Customizable Light Regimes
05:21

Operation of Laboratory Photobioreactors with Online Growth Measurements and Customizable Light Regimes

Published on: October 28, 2021

2.6K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacovigilance

Background:

  • Individualized treatment improves clinical outcomes but often involves side effects.
  • Balancing treatment efficacy and safety is crucial for optimal patient care.

Purpose of the Study:

  • To develop a competing risks model for optimizing treatment regimes.
  • To define a restricted optimal treatment regime considering both event incidence and side effects.

Main Methods:

  • Modeling time to primary events and severe side effects using competing risks.
  • Estimating the optimal regime via a penalized value search method.
  • Validating the approach through extensive simulations.

Main Results:

  • The proposed method effectively models competing risks in treatment outcomes.
  • Simulation studies demonstrate the robustness and accuracy of the estimation approach.
  • Application to an HIV dataset shows minimization of treatment failures while managing side effect risks.

Conclusions:

  • The competing risks framework provides a robust approach to defining optimal treatment regimes.
  • This method aids in balancing therapeutic benefits with the risk of adverse events.
  • The approach is applicable to complex clinical scenarios, such as HIV treatment management.